Impact of aging vs. estrogen loss on cardiac gene expression: Estrogen replacement and inflammation

Angela S. Pechenino, Li Lin, Fiona N. Mbai, Alison R. Lee, Xian Min He, John N. Stallone, Anne A Knowlton

Research output: Contribution to journalArticle

31 Citations (Scopus)

Abstract

Despite an abundance of evidence to the contrary from animal studies, large clinical trials on humans have shown that estrogen administered to postmenopausal women increases the risk of cardiovascular disease. However, timing may be everything, as estrogen is often administered immediately after ovariectomy (Ovx) in animal studies, while estrogen administration in human studies occurred many years postmenopause. This study investigates the discrepancy by administering 17β-estradiol (E2) in a slow-release capsule to Norway Brown rats both immediately following Ovx and 9 wk post-Ovx (Late), and studying differences in gene expression between these two groups compared with age-matched Ovx and sham-operated animals. Two different types of microarray were used to analyze the left ventricles from these groups: an Affymetrix array (n = 3/group) and an inflammatory cytokines and receptors PCR array (n = 4/group). Key genes were analyzed by Western blotting. Ovx without replacement led to an increase in caspase 3, caspase 9, calpain 2, matrix metalloproteinase (MMP)9, and TNF-α. Caspase 6, STAT3, and CD11b increased in the Late group, while tissue inhibitor of metalloproteinase 2, MMP14, and collagen I α1 were decreased. MADD and fibronectin were increased in both Ovx and Late. TNF-α and inducible nitric oxide synthase (iNOS) protein levels increased with Late replacement. Many of these changes were prevented by early E2 replacement. These findings suggest that increased expression of inflammatory genes, such as TNF-α and iNOS, may be involved in some of the deleterious effects of delayed E2 administration seen in human studies.

Original languageEnglish (US)
Pages (from-to)1065-1073
Number of pages9
JournalPhysiological Genomics
Volume43
Issue number18
DOIs
StatePublished - Sep 2011

Fingerprint

Estrogen Replacement Therapy
Estrogens
Nitric Oxide Synthase Type II
Inflammation
Gene Expression
Caspase 6
Postmenopause
Tissue Inhibitor of Metalloproteinase-2
Cytokine Receptors
Calpain
Caspase 9
Matrix Metalloproteinase 9
Ovariectomy
Fibronectins
Caspase 3
Heart Ventricles
Capsules
Estradiol
Cardiovascular Diseases
Collagen

Keywords

  • Cardiovascular disease
  • Timing hypothesis

ASJC Scopus subject areas

  • Physiology
  • Genetics

Cite this

Impact of aging vs. estrogen loss on cardiac gene expression : Estrogen replacement and inflammation. / Pechenino, Angela S.; Lin, Li; Mbai, Fiona N.; Lee, Alison R.; He, Xian Min; Stallone, John N.; Knowlton, Anne A.

In: Physiological Genomics, Vol. 43, No. 18, 09.2011, p. 1065-1073.

Research output: Contribution to journalArticle

Pechenino, Angela S. ; Lin, Li ; Mbai, Fiona N. ; Lee, Alison R. ; He, Xian Min ; Stallone, John N. ; Knowlton, Anne A. / Impact of aging vs. estrogen loss on cardiac gene expression : Estrogen replacement and inflammation. In: Physiological Genomics. 2011 ; Vol. 43, No. 18. pp. 1065-1073.
@article{f8f946edb8d84eff8432cdf0a5b61625,
title = "Impact of aging vs. estrogen loss on cardiac gene expression: Estrogen replacement and inflammation",
abstract = "Despite an abundance of evidence to the contrary from animal studies, large clinical trials on humans have shown that estrogen administered to postmenopausal women increases the risk of cardiovascular disease. However, timing may be everything, as estrogen is often administered immediately after ovariectomy (Ovx) in animal studies, while estrogen administration in human studies occurred many years postmenopause. This study investigates the discrepancy by administering 17β-estradiol (E2) in a slow-release capsule to Norway Brown rats both immediately following Ovx and 9 wk post-Ovx (Late), and studying differences in gene expression between these two groups compared with age-matched Ovx and sham-operated animals. Two different types of microarray were used to analyze the left ventricles from these groups: an Affymetrix array (n = 3/group) and an inflammatory cytokines and receptors PCR array (n = 4/group). Key genes were analyzed by Western blotting. Ovx without replacement led to an increase in caspase 3, caspase 9, calpain 2, matrix metalloproteinase (MMP)9, and TNF-α. Caspase 6, STAT3, and CD11b increased in the Late group, while tissue inhibitor of metalloproteinase 2, MMP14, and collagen I α1 were decreased. MADD and fibronectin were increased in both Ovx and Late. TNF-α and inducible nitric oxide synthase (iNOS) protein levels increased with Late replacement. Many of these changes were prevented by early E2 replacement. These findings suggest that increased expression of inflammatory genes, such as TNF-α and iNOS, may be involved in some of the deleterious effects of delayed E2 administration seen in human studies.",
keywords = "Cardiovascular disease, Timing hypothesis",
author = "Pechenino, {Angela S.} and Li Lin and Mbai, {Fiona N.} and Lee, {Alison R.} and He, {Xian Min} and Stallone, {John N.} and Knowlton, {Anne A}",
year = "2011",
month = "9",
doi = "10.1152/physiolgenomics.00228.2010",
language = "English (US)",
volume = "43",
pages = "1065--1073",
journal = "Physiological Genomics",
issn = "1094-8341",
publisher = "American Physiological Society",
number = "18",

}

TY - JOUR

T1 - Impact of aging vs. estrogen loss on cardiac gene expression

T2 - Estrogen replacement and inflammation

AU - Pechenino, Angela S.

AU - Lin, Li

AU - Mbai, Fiona N.

AU - Lee, Alison R.

AU - He, Xian Min

AU - Stallone, John N.

AU - Knowlton, Anne A

PY - 2011/9

Y1 - 2011/9

N2 - Despite an abundance of evidence to the contrary from animal studies, large clinical trials on humans have shown that estrogen administered to postmenopausal women increases the risk of cardiovascular disease. However, timing may be everything, as estrogen is often administered immediately after ovariectomy (Ovx) in animal studies, while estrogen administration in human studies occurred many years postmenopause. This study investigates the discrepancy by administering 17β-estradiol (E2) in a slow-release capsule to Norway Brown rats both immediately following Ovx and 9 wk post-Ovx (Late), and studying differences in gene expression between these two groups compared with age-matched Ovx and sham-operated animals. Two different types of microarray were used to analyze the left ventricles from these groups: an Affymetrix array (n = 3/group) and an inflammatory cytokines and receptors PCR array (n = 4/group). Key genes were analyzed by Western blotting. Ovx without replacement led to an increase in caspase 3, caspase 9, calpain 2, matrix metalloproteinase (MMP)9, and TNF-α. Caspase 6, STAT3, and CD11b increased in the Late group, while tissue inhibitor of metalloproteinase 2, MMP14, and collagen I α1 were decreased. MADD and fibronectin were increased in both Ovx and Late. TNF-α and inducible nitric oxide synthase (iNOS) protein levels increased with Late replacement. Many of these changes were prevented by early E2 replacement. These findings suggest that increased expression of inflammatory genes, such as TNF-α and iNOS, may be involved in some of the deleterious effects of delayed E2 administration seen in human studies.

AB - Despite an abundance of evidence to the contrary from animal studies, large clinical trials on humans have shown that estrogen administered to postmenopausal women increases the risk of cardiovascular disease. However, timing may be everything, as estrogen is often administered immediately after ovariectomy (Ovx) in animal studies, while estrogen administration in human studies occurred many years postmenopause. This study investigates the discrepancy by administering 17β-estradiol (E2) in a slow-release capsule to Norway Brown rats both immediately following Ovx and 9 wk post-Ovx (Late), and studying differences in gene expression between these two groups compared with age-matched Ovx and sham-operated animals. Two different types of microarray were used to analyze the left ventricles from these groups: an Affymetrix array (n = 3/group) and an inflammatory cytokines and receptors PCR array (n = 4/group). Key genes were analyzed by Western blotting. Ovx without replacement led to an increase in caspase 3, caspase 9, calpain 2, matrix metalloproteinase (MMP)9, and TNF-α. Caspase 6, STAT3, and CD11b increased in the Late group, while tissue inhibitor of metalloproteinase 2, MMP14, and collagen I α1 were decreased. MADD and fibronectin were increased in both Ovx and Late. TNF-α and inducible nitric oxide synthase (iNOS) protein levels increased with Late replacement. Many of these changes were prevented by early E2 replacement. These findings suggest that increased expression of inflammatory genes, such as TNF-α and iNOS, may be involved in some of the deleterious effects of delayed E2 administration seen in human studies.

KW - Cardiovascular disease

KW - Timing hypothesis

UR - http://www.scopus.com/inward/record.url?scp=80053163686&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053163686&partnerID=8YFLogxK

U2 - 10.1152/physiolgenomics.00228.2010

DO - 10.1152/physiolgenomics.00228.2010

M3 - Article

C2 - 21750230

AN - SCOPUS:80053163686

VL - 43

SP - 1065

EP - 1073

JO - Physiological Genomics

JF - Physiological Genomics

SN - 1094-8341

IS - 18

ER -